By Jeff Swiatek, The Indianapolis Star Knight Ridder/Tribune Business News
Oct. 17--Guidant Corp.'s sales hit a record high $938 million in the third quarter, but profit fell 26 percent from a year ago as competing drug-coated heart stents cut into Guidant's once-dominant bare-metal stent business.
The Indianapolis medical device maker said sales of its stents fell 14 percent, to $200 million, in the latest quarter from the year-ago period, and U.S. stent sales now contribute just 10 percent of total sales.
A new type of stent by Johnson & J